- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05477745
The Correlation Between Femoral Component Implanting Flexion Angle and Posterior Condyle Offset in Cruciate Retaining Total Knee Arthroplasty
July 27, 2022 updated by: RenJi Hospital
The main aim and scope is making measurement and comparison about the femoral component posterior offset under different femoral component implanting flexion angle in cruciate retaining total knee arthroplasty.
The results may identify the influence of the flexion component implanting flexion angle on the femoral component posterior offset.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
200
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All the patients were treated with primary total knee arthroplasty in Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine.
Description
Inclusion Criteria:
- The patients undertaken the primary cruciate retaining total knee arthroplasty;
- using the curiate retaining total knee arthroplasty prothesis from Biomet and Smith&Nephew;
- Complete surgery documents and radiologic data,such as standard X-ray postoperative both at antirior-posterior position and medial-lateral position(overlap of the medial and lateral femoral condyle).
Exclusion Criteria:
- The patients without standard X-ray postoperative both at antirior-posterior position and medial-lateral position(poor overlap of the medial and lateral femoral condyle);
- Complex primary total knee arthroplasty, using extra component such as trabecular metal,stem or et al.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
The group that the sagittal flexion angle of the femoral component less than 4°
The patients' knees were taken on the X-ray examination after the total knee arthroplasty on the medial-lateral position.
The flexion (positive degree) or extension (negative degree) angle of the femoral component according to the anterior femoral cortex was measured.
The patients with the sagittal flexion angle of the femoral component less than 4° were categorized into this group.
|
The surgeries were performed under general anesthesia.
The medial parepatellar incision was introduced during the TKA.
The femoral component size was selected according to the intro-operative measurement.
The osteotomy was done according to the intramedullary guide and the cutting guide.
After the proximal tibial osteotomy was finished, the cruciate-retaining Total Knee System was used.
The lateral rotation of the femoral component was determined by the gap-balancing technique.
|
|
The group that the sagittal flexion angle of the femoral component over 4°
The patients' knees were taken on the X-ray examination after the total knee arthroplasty on the medial-lateral position.
The flexion (positive degree) or extension (negative degree) angle of the femoral component according to the anterior femoral cortex was measured.
The patients with the sagittal flexion angle of the femoral component over 4° were categorized into this group.
|
The surgeries were performed under general anesthesia.
The medial parepatellar incision was introduced during the TKA.
The femoral component size was selected according to the intro-operative measurement.
The osteotomy was done according to the intramedullary guide and the cutting guide.
After the proximal tibial osteotomy was finished, the cruciate-retaining Total Knee System was used.
The lateral rotation of the femoral component was determined by the gap-balancing technique.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Posterior Femoral Offset
Time Frame: 1 week after the surgery
|
The posterior femoral offset was defined as the maximal thickness of the posterior condyle projecting posteriorly to a straight line drawn as the extension of the posterior femoral shaft cortex on the medial-lateral position of the X-ray examination.
|
1 week after the surgery
|
|
Posterior Femoral Offset Ratio
Time Frame: 1 week after the surgery
|
The posterior femoral offset ratio was defined as the maximal thickness of the posterior condyle projecting posteriorly to a straight line drawn as the extension of the posterior femoral shaft cortex, divided by the maximal thickness of the posterior condyle projecting posterior to a straight line drawn as the extension of the anterior femoral shaft contex on the medial-lateral position of the X-ray examination.
|
1 week after the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
July 29, 2022
Primary Completion (ANTICIPATED)
August 15, 2022
Study Completion (ANTICIPATED)
August 22, 2022
Study Registration Dates
First Submitted
July 25, 2022
First Submitted That Met QC Criteria
July 27, 2022
First Posted (ACTUAL)
July 28, 2022
Study Record Updates
Last Update Posted (ACTUAL)
July 28, 2022
Last Update Submitted That Met QC Criteria
July 27, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIT-2022-0048
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.